Who owns QUINCE THERAPEUTICS INC COM?
- CUSIP Number: 22053a206
Tip: Access positions for across all investors
Analyze quarterly positions in Quince Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Quince Therapeutics stock
Who bought or sold QUINCE THERAPEUTICS INC COM this quarter?
There are no current stakeholders of Quince Therapeutics.
This is normal when the security:
- Has been acquired or taken private
- Has merged with another entity
- Has changed its name and has a new CUSIP (and/or symbol)
- Has been delisted and the ticker has changed
Please use Search to find the security you were looking for.
Who sold out of Quince Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Tudor Investment Corporation | Mar 2026 | 220k | $22k |
| Gen-Wealth Partners | Mar 2026 | 33k | $3.3k |
| Catalyst Funds Management Pty | Mar 2026 | 30k | $3.0k |
| Fortitude Family Office | Mar 2026 | 8.1k | $820.833000 |
| Advisory Services Network | Mar 2026 | 5.5k | $558.250000 |
| Parallel Advisors | Mar 2026 | 795.00 | $81.010500 |
| SBI Securities | Mar 2026 | 135.00 | $13.999500 |